Venture Life Group (LON:VLG) Reaches New 52-Week High – Still a Buy?

Posted by Donald Scott on Dec 29th, 2025

Venture Life Group plc (LON:VLG – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 67 and last traded at GBX 65.85, with a volume of 229168 shares. The stock had previously closed at GBX 65.50.

Venture Life Group Trading Up 0.5%

The firm’s fifty day simple moving average is GBX 59.16 and its 200 day simple moving average is GBX 57.68. The stock has a market capitalization of £84.03 million, a P/E ratio of -86.64, a price-to-earnings-growth ratio of 5.67 and a beta of 0.30. The company has a debt-to-equity ratio of 28.45, a quick ratio of 1.48 and a current ratio of 2.22.

Venture Life Group (LON:VLG – Get Free Report) last posted its quarterly earnings results on Tuesday, September 30th. The company reported GBX 0.83 earnings per share (EPS) for the quarter. Venture Life Group had a net margin of 1.44% and a return on equity of 0.99%. As a group, equities research analysts forecast that Venture Life Group plc will post 6.1391542 EPS for the current fiscal year.

Insider Buying and Selling at Venture Life Group

In other Venture Life Group news, insider Mark Adams purchased 88,999 shares of the firm’s stock in a transaction dated Friday, October 3rd. The shares were bought at an average price of GBX 56 per share, for a total transaction of £49,839.44. Corporate insiders own 6.84% of the company’s stock.

About Venture Life Group

(Get Free Report)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.

With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.